EcoDrugPlus

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSPKIG00000007150
Gene Symbol: LOC111837704
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSPKIG00000009302
Gene Symbol: LOC111854546
3 Cross references
196 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSPKIG00000012939
Gene Symbol: MTOR
1 Cross references
218 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSPKIG00000019904
Gene Symbol: MC1R
3 Cross references
158 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSPKIG00000006652
Gene Symbol: MC3R
3 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSPKIG00000011636
Gene Symbol: MC4R
2 Cross references
106 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSPKIG00000015588
Gene Symbol: MC4R
1 Cross references
106 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSPKIG00000024139
Gene Symbol: MTNR1A
3 Cross references
188 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSPKIG00000009748
Gene Symbol: MME
4 Cross references
234 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSPKIG00000025045
Gene Symbol: LOC111842401
3 Cross references
214 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSPKIG00000002262
Gene Symbol: LOC111854385
3 Cross references
211 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSPKIG00000014889
Gene Symbol: METAP2B
2 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).